A comparative economic analysis of pegylated liposomal doxorubicin versus topotecan in ovarian cancer in the USA and the UK
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/13/10/1590/400078/mdf275.pdf
Reference31 articles.
1. Economic analyses of phase III cooperative cancer group clinical trials: are they feasible?;Bennett;Cancer Invest,1997
2. Users’ guides to the medical literature. XIII. How to use an article on economic analysis of clinical practice. A. Are the results of the study valid? Evidence-Based Medicine Working Group;Drummond;JAMA,1997
3. Economic and policy implications of adopting paclitaxel as first-line therapy for advanced ovarian cancer: an Ontario perspective;Elit;J Clin Oncol,1997
4. Analysis of the cost-effectiveness of paclitaxel as alternative combination therapy for advanced ovarian cancer;McGuire;J Clin Oncol,1997
5. Cost analysis of second-line therapies for platinum-refractory ovarian cancer: reimbursement dilemmas for Medicare patients;Stinson;Cancer Invest,1999
Cited by 61 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cost-effectiveness of durvalumab plus tremelimumab in combination with chemotherapy for the treatment of metastatic non-small-cell lung cancer from the US healthcare sector’s and societal perspectives;Frontiers in Pharmacology;2024-06-10
2. Dostarlimab for recurrent mismatch repair‐deficient endometrial cancer: A cost‐effectiveness study;BJOG: An International Journal of Obstetrics & Gynaecology;2022-11-21
3. Cardiotoxicity of anticancer drugs and radiotherapy in patients with hematologic malignancies and solid tumors;Oncohematology;2022-07-20
4. Cardiotoxicity of anthracyclines and targeted anti-HER2/neu therapy in treatment of oncological patients;MD-Onco;2022-06-02
5. Nanoparticle based medicines: approaches for evading and manipulating the mononuclear phagocyte system and potential for clinical translation;Biomaterials Science;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3